Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2000
11/09/2000WO2000066559A1 Piperidine derivatives useful as ccr5 antagonists
11/09/2000WO2000066558A1 Piperazine derivatives useful as ccr5 antagonists
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000066159A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/09/2000WO2000066156A1 Death domain containing receptor 5
11/09/2000WO2000066151A1 Use of heparin-binding antagonists in the inhibition of bradykinin release
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066135A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000WO2000066134A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000WO2000066131A1 Anti-irritant compositions containing a cyclic 2'-deoxy-nucleotide
11/09/2000WO2000066123A1 Synergistic combination comprising roflumilast and a pde-3 inhibitor
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066111A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000WO2000066107A2 Antimalarian agents for the treatment of asthma
11/09/2000WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000066102A2 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
11/09/2000WO2000066094A2 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000WO2000066086A1 Anti-inflammatory bioactive glass particulates
11/09/2000WO2000066067A2 Ibd-associated microbial antigens and methods of using same
11/09/2000WO2000051968A8 Method for the preparation of a chiral-beta-amino ester
11/09/2000WO2000040592A8 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
11/09/2000WO2000035906A3 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
11/09/2000WO2000034477A3 Neuron-associated proteins
11/09/2000WO2000034447A3 Human ubiquitin ligase e3 for the modulation of nf-kappa b
11/09/2000WO2000032624A3 Uncoupling protein 5 - ucp5
11/09/2000WO2000032584A3 Nonsteroidal antiinflammatories
11/09/2000WO2000030671A3 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
11/09/2000WO2000027422A3 Methods and compositions for treating or preventing peripheral neuropathies
11/09/2000WO2000021996A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000010968A3 Novel aryl sulphonamide amino acid esters and analogues
11/09/2000WO2000004050A3 Neurotrophic growth factor
11/09/2000WO2000001349A3 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
11/09/2000DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372803A1 Variants of traf2 which act as an inhibitor of tnf-alpha (tnf .alpha.) signaling pathway
11/09/2000CA2372772A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000CA2372493A1 Steroid derivatives
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372223A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000CA2372220A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371671A1 Pyrimidinone compounds
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2371421A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/09/2000CA2371391A1 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
11/09/2000CA2370587A1 Use of heparin-binding antagonists in the inhibition of bradykinin release
11/09/2000CA2370304A1 Specific antibodies and antibody fragments for tgf.beta.1
11/09/2000CA2369526A1 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000CA2369371A1 Death domain containing receptor 5
11/09/2000CA2365258A1 Heteroaryl diazabicycloalkanes, their preparation and use
11/09/2000CA2336362A1 Anti-irritant compositions containing a cyclic 2'-deoxy-nucleotide
11/08/2000EP1050530A1 1-Aza-2-alkyl-6-aryl-cycloalkanes usefull as memory enhancers
11/08/2000EP1049776A1 Phagocytosis genes and uses thereof
11/08/2000EP1049775A1 Human btrcp protein
11/08/2000EP1049773A1 Inhibition of cytokine production
11/08/2000EP1049770A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049717A2 Antibodies against human il-12
11/08/2000EP1049714A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049703A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049699A1 Azolo triazines and pyrimidines
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049693A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS
11/08/2000EP1049689A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
11/08/2000EP1049677A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
11/08/2000EP1049676A1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
11/08/2000EP1049673A1 Heterocyclic amidines as callicrein protease inhibitors
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/08/2000EP1049476A1 Pharmaceutical compositions for mucolysis and treatment of inflammation
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP1049459A1 Oral liquid compositions
11/08/2000EP1049441A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
11/08/2000EP0652872B1 Optically pure magnesium -salt of pyridinylmethyl sulfinyl-1h-benzimidazole compound
11/08/2000CN1272886A Polynucleotide encoding polypeptide having heparanase activity and expression of same in transduced cells
11/08/2000CN1272884A Adipocyte-specific protein homologs
11/08/2000CN1272840A Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
11/08/2000CN1058181C Health-care wine made of cattle penis
11/08/2000CN1058150C Topical aromatic releasing compositions
11/07/2000US6143785 Inflammatory bowel disease with alkanoyl carnitine in solution
11/07/2000US6143782 Anti-inflammatory and anti-asthma treatment with reduced side effects
11/07/2000US6143775 Physical form of zafirlukast; asthma
11/07/2000US6143771 Benzimidazole derivative drugs
11/07/2000US6143770 Mixtures of tocotrienol and nicotinic acid
11/07/2000US6143751 Pyridine derivatives and pharmaceutical compositions containing them
11/07/2000US6143749 Heterocyclic substituted cyclopentane compounds
11/07/2000US6143746 Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
11/07/2000US6143730 As anti-angiogenic, anti-metastatic and/or anti-inflammatory agents
11/07/2000US6143728 Guanylhydrazones useful for treating diseases associated with T cell activation
11/07/2000US6143724 Used for treatment, improvement and prevention of inflammation and diseases accompanying inflamation
11/07/2000US6143722 To controll uterine contractions in treating preterm labor
11/07/2000US6143544 Human lysophospholipase
11/07/2000US6143501 Inducing artificial three-dimensional tissues using cell interaction systems such that cultures possessing or developing extracellular matrix are linked via membranes, or are in direct contact with or are mixed with each other
11/07/2000US6143331 Homogenizing using aqueous solution; separation; ultrafiltration
11/07/2000CA2170485C Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
11/07/2000CA2166981C Oncoprotein protein kinase
11/02/2000WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000WO2000064936A2 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2
11/02/2000WO2000064904A1 5,7-bicyclic amidine derivatives useful as nitric oxide synthase inhibitors
1 ... 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 ... 1272